Time to reconsider moxifloxacin anti-anaerobic activity?

Luigi Principea Clinical Pathology and Microbiology Unit, “San Giovanni di Dio” Hospital, Crotone, ItalyCorrespondence[email protected]
View further author information

Gianfranco Sansonb Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, ItalyView further author information

Roberto Luzzatib Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, ItalyView further author information

Richard Aschbacherc Microbiology and Virology Laboratory, Health Service of Bolzano, Bolzano, ItalyView further author information

Elisabetta Paganic Microbiology and Virology Laboratory, Health Service of Bolzano, Bolzano, ItalyView further author information

Francesco Luzzarod Clinical Microbiology and Virology Unit, “A. Manzoni” Hospital, Lecco, ItalyView further author information

Stefano Di Bellab Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, ItalyView further author information

show all

References

Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe. 2015;31:4–10.
PubMed Web of Science ®Google Scholar
Nagy E, Urbán E, Nord CE. ESCMID study group on antimicrobial resistance in anaerobic bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17(3):371–379.
PubMed Web of Science ®Google Scholar
Spigaglia P, Barbanti F, Dionisi AM, et al. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol. 2010;48(8):2892–2896.
PubMed Web of Science ®Google Scholar
König E, Ziegler HP, Tribus J, et al. Surveillance of antimicrobial susceptibility of anaerobe clinical isolates in southeast Austria: group is on the fast track to resistance. Antibiotics Basel. 2021;10(5):479.
PubMed Web of Science ®Google Scholar
Di Bella S, Antonello RM, Sanson G, et al. Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey. Anaerobe. 2022;75:102583.
PubMed Web of Science ®Google Scholar
Cobo F, Borrego J, Gómez E, et al. Clinical finding and antimicrobial susceptibility of anaerobic bacteria isolated in bloodstream infections. Antibiotics Basel. 2020;9(6):345.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Time to reconsider moxifloxacin anti-anaerobic activity?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Time to reconsider moxifloxacin anti-anaerobic activity?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date